Obesity Treatment: Study Backs Dual-Drug Strategy

In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using sibutramine-topiramate.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/obesity-treatment-study-backs-dual-drug-strategy-2025a1000pu3?src=rss

Author :

Publish date : 2025-09-26 13:35:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Obesity Treatment: Study Backs Dual-Drug Strategy

Should You Be Satisfied With ‘Just’ a Medical Degree?

‘TikTok Challenge’ Death; RFK Jr. Mulls Vax Injury $$ for Autism; Top Sugar Recalled

Related Posts

‘The pain was so agonizing, I walked with a stick’

If Government Shuts Down, Federal Health Programs Would Feel the Pinch

After Massive Shrimp Recalls, FDA Finds Radioactive Contamination in Spices Too

Acupuncture Eases Chronic Low Back Pain, Boosts Function

GLP-1 Drugs Show Benefits in Lupus Patients With Diabetes

Women With Alzheimer’s Show Unique Fatty Acid Deficits

‘The pain was so agonizing, I walked with a stick’

If Government Shuts Down, Federal Health Programs Would Feel the Pinch

After Massive Shrimp Recalls, FDA Finds Radioactive Contamination in Spices Too

Acupuncture Eases Chronic Low Back Pain, Boosts Function

GLP-1 Drugs Show Benefits in Lupus Patients With Diabetes

Women With Alzheimer’s Show Unique Fatty Acid Deficits

Targeted Kinase Inhibitor Active in Cicatricial Alopecias

Dana-Farber Oncologist Could Be Next NCI Director, Reports Say

Categories

Archives